US$ 29.01
lumme glp 1 GLP-1 Metabolic PRO GLP-1 supplements promise to curb
Description
Clinical development update on orforglipron (GLP-1 receptor agonist)
Offer a Basic medication plan and a Premium plan including 1-on-1 nutrition coaching

Outeirino-Iglesias, V., Romani-Perez, M., Gonzalez-Matias, L

In combination with glimepiride, with or without metformin, the overall incidence of clinical adverse reactions with Januvia was higher than with placebo, in part related to a higher incidence of hypoglycemia (see Table 1)

Bulchandani et al., 2012

The American College of Physicians recommends adding either an SGLT2 inhibitor or a GLP-1 agonist to metformin when blood sugar control is insufficient, allowing for a more tailored treatment approach
